Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 | NEJM Original Article from The New England Journal of Medicine — Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

MedSky🧪#IDSky #Drugsdevelopment #Clinicaltrial Evaluate the Efficacy and Safety of SIM0417 /Oral #Simnotrelvir Orally Co-Administered With #Ritonavir in Symptomatic Adult Participants With Mild to Moderate #COVID19

www.nejm.org/doi/10.1056/...

MedSky🧪 #IDSky +ve trial results of #simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate #COVID19 symptoms. Unlike with Paxlovid or other antivirals tested against the virus,
www.nejm.org/doi/full/10....